RecallDepth
Class II Terminated

Zileuton Extended-Release Tablets, 600 mg, 120-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD 21202 by Lupin Limited, Nagpur-441108, India, NDC 68180-169-16

Company
Lupin Pharmaceuticals Inc.
Recall Initiated
June 10, 2022
Posted
June 22, 2022
Recall Number
D-1150-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
3,216 bottles
Firm Location
Baltimore, MD, United States

Reason for Recall

Failed Dissolution Specifications: Out of specification test results observed in dissolution testing during long term stability study.

Distribution

Product was distributed to 10 wholesalers/distributors and one mail order account who may have further distributed the product nationwide.

Lot / Code Info

Lots: M100070, M100239, Exp. 06/22, M100312, Exp.09/22, M100366, Exp.10/22

More recalls by Lupin Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls